Coverage
-
October 07, 2022
Quest Diagnostics Inc. reached a deal with Ravgen Inc. resolving the small biotech business' claims that Quest infringed its prenatal genetic test patents ahead of a trial set to kick off Tuesday in California federal court.
1 other articles on this case.
View all »